Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Colorectal Adenoma Risk Is Increased among Recently Diagnosed Adult Celiac Disease Patients.

Lasa J, Rausch A, Bracho LF, Altamirano J, Speisky D, de Dávila MTG, Iotti A, Zubiaurre I.

Gastroenterol Res Pract. 2018 Apr 23;2018:6150145. doi: 10.1155/2018/6150145. eCollection 2018.

2.

In vitro, in vivo and ex vivo demonstration of the antitumoral role of hypocretin-1/orexin-A and almorexant in pancreatic ductal adenocarcinoma.

Dayot S, Speisky D, Couvelard A, Bourgoin P, Gratio V, Cros J, Rebours V, Sauvanet A, Bedossa P, Paradis V, Ruszniewski P, Couvineau A, Voisin T.

Oncotarget. 2018 Jan 9;9(6):6952-6967. doi: 10.18632/oncotarget.24084. eCollection 2018 Jan 23.

3.

Hepatic metastasis of thymoma: case report and immunohistochemical study.

Speisky D, de Davila MT, Vigovich F, Mendez J, Maurette R, Ejarque MG, Spina JC, Iotti A, Dezanzo P.

Ecancermedicalscience. 2016 Nov 22;10:693. doi: 10.3332/ecancer.2016.693. eCollection 2016.

4.

Somatostatin receptor subtype 2 expression and somatostatin receptor scintigraphy positivity in pancreatic serous cystadenomas.

Poté N, Lebtahi R, Hentic O, Speisky D, Sauvanet A, Vullierme MP, Bedossa P, Ruszniewski P, Couvelard A.

Pancreas. 2015 May;44(4):672-4. doi: 10.1097/MPA.0000000000000319. No abstract available.

PMID:
25872132
5.

Molecular profiling of pancreatic neuroendocrine tumors in sporadic and Von Hippel-Lindau patients.

Speisky D, Duces A, Bièche I, Rebours V, Hammel P, Sauvanet A, Richard S, Bedossa P, Vidaud M, Murat A, Niccoli P, Scoazec JY, Ruszniewski P, Couvelard A; GTE Group, Groupe d'Etude des Tumeurs Endocrines.

Clin Cancer Res. 2012 May 15;18(10):2838-49. doi: 10.1158/1078-0432.CCR-11-2759. Epub 2012 Mar 29.

Supplemental Content

Loading ...
Support Center